- active not recruiting
Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma
This study looks at how neuroblastoma treatment affects children and young adults years later. We want to understand these long-term effects to help improve future treatments and quality of life for survivors.
United States · Australia · Canada - recruitingPHASE1, PHASE2
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
This study looks at new drug combinations (Onivyde with talazoparib or temozolomide) for children and young adults with solid cancers that have come back or not responded to previous treatment, especially Ewing sarcoma. The aim is to find the safest, most effective dose.
United States · Canada - active not recruitingPHASE2
Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma
This study looks at new ways to treat neuroblastoma that has come back or isn't responding to usual treatments. It tests if adding a drug called eflornithine to other medicines helps children with this type of cancer.
United States · Australia · Canada